Dr Humayun Speciality Hospital Profile
Key Indicators
- Authorised Capital ₹ 13.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 12.00 Cr
as on 06-07-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 37.00 Cr
as on 06-07-2024
- Revenue %
(FY 2023)
- Profit 643.13%
(FY 2023)
- Ebitda 61.95%
(FY 2023)
- Net Worth 6.16%
(FY 2023)
- Total Assets 435.40%
(FY 2023)
About Dr Humayun Speciality Hospital
The Corporate was formerly known as Madras Unity Hopsitals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 13.00 Cr and a paid-up capital of Rs 12.00 Cr.
The company currently has active open charges totaling ₹37.00 Cr.
Sulaiman Mohammed, Asma Begum, and Humayun Sulaiman serve as directors at the Company.
- CIN/LLPIN
U85100TN2019PTC127521
- Company No.
127521
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Feb 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Dr Humayun Speciality Hospital?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sulaiman Mohammed  | Director | 15-Feb-2019 | Current |
| Asma Begum | Director | 15-Feb-2019 | Current |
| Humayun Sulaiman | Director | 15-Feb-2019 | Current |
Financial Performance and Corporate Structure Insights of Dr Humayun Speciality Hospital.
Dr Humayun Speciality Hospital Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 643.13% increase in profit. The company's net worth moved up by a moderate rise of 6.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr Humayun Speciality Hospital?
In 2023, Dr Humayun Speciality Hospital had a promoter holding of 58.33% and a public holding of 41.67%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Steril-Gene Life Sciences Private LimitedActive 17 years 9 monthsSulaiman Mohammed is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 06 Apr 2022 | ₹37.00 Cr | Open |
How Many Employees Work at Dr Humayun Speciality Hospital?
Unlock and access historical data on people associated with Dr Humayun Speciality Hospital, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr Humayun Speciality Hospital, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr Humayun Speciality Hospital's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
